PD-1 antibody was approved as first-line treatment for locally recurrent or metastatic squamous cell anal carcinoma.

Leading oncologists said AI will one day be as integrated into cancer care as it is in smartphones and self-driving cars. #STATBreakthrough ...

After delaying her screening, a judge lays down the law on breast cancer with help from Methodist Midlothian Medical Center.

King Charles connected with one of his guests over the shared experience of undergoing cancer treatment during a recent ...

With two concurrent FDA approvals, Incyte’s PD-1 inhibitor Zynyz has redeemed itself in anal cancer four years after an ...

At the recent American Urological Association (AUA) annual meeting, focal therapies for localized prostate cancer took center ...

Recently, Visionary has achieved a significant breakthrough in the field of early cancer screening and home self - testing technologies, attracting widespread attention from the industry.

Melani Vincelli walked into a doctor’s office wondering if she had an ulcer. Today, she’s approaching her 65th birthday as a ...

This is a timeline of the lawsuit involving Hannibal Regional Healthcare System and its push to bring cancer treatment to ...

Subungual melanoma which appears under fingernails and toenails, is a rare but serious form of skin cancer that typically isn ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

31-year-old Scott Hinch was told that he may only have 3 to 5 years to live and this news rightly floored him. Doctors only ...